Polar Capital’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
$75.8M Buy
1,256,451
+1,034,045
+465% +$62.2M 0.56% 51
2020
Q2
$13.1M Sell
222,406
-1,414,656
-86% -$84.6M 0.11% 156
2020
Q1
$91.3M Buy
1,637,062
+586,667
+56% +$35.9M 0.98% 19
2019
Q4
$67.4M Buy
+1,050,395
New +$60.2M 0.59% 41
2017
Q2
Sell
-190,000
Closed -$10.3M 244
2017
Q1
$10.3M Buy
190,000
+40,000
+27% +$2.19M 0.15% 142
2016
Q4
$8.77M Buy
150,000
+50,000
+50% +$2.73M 0.14% 162
2016
Q3
$5.39M Sell
100,000
-605,000
-86% -$38.9M 0.09% 173
2016
Q2
$51.9M Buy
705,000
+585,000
+488% +$41.3M 0.98% 29
2016
Q1
$7.66M Sell
120,000
-578,070
-83% -$36.5M 0.14% 150
2015
Q4
$48M Buy
698,070
+538,070
+336% +$35.6M 0.87% 37
2015
Q3
$9.47M Hold
160,000
0.19% 149
2015
Q2
$10.6M Hold
160,000
0.2% 139
2015
Q1
$10.3M Hold
160,000
0.2% 141
2014
Q4
$9.44M Hold
160,000
0.18% 146
2014
Q3
$8.19M Hold
160,000
0.17% 158
2014
Q2
$7.76M Hold
160,000
0.17% 164
2014
Q1
$8.31M Hold
160,000
0.19% 162
2013
Q4
$8.5M Hold
160,000
0.2% 168
2013
Q3
$7.4K Hold
160,000
0.2% 168
2013
Q2
$7.15M Buy
+160,000
New +$6.95M 0.25% 153

Other funds holding BMY

Polar Capital's BMY Position: Q3 2020 in Review

Polar Capital increased its Bristol-Myers Squibb (BMY) stake by 465% in Q3 2020, buying an estimated $62.2M and bringing the position to 1,256,451 shares worth $75.8M. The position accounts for 0.56% of the portfolio, ranked #51.

Polar Capital first reported a position in BMY in Q2 2013 and has held it in 20 quarters since. The position peaked at $91.3M in Q1 2020. 2,214 funds tracked by Wall St. Rank hold BMY as of Q3 2020.

  • Polar Capital held 1,256,451 shares of Bristol-Myers Squibb worth $75.8M as of Q3 2020.
  • Polar Capital bought 1,034,045 Bristol-Myers Squibb shares in Q3 2020, an estimated $62.2M.
  • Bristol-Myers Squibb made up 0.56% of Polar Capital's portfolio in Q3 2020, its #51 holding.
  • Polar Capital first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 20 quarters since.
  • Polar Capital's Bristol-Myers Squibb position peaked at $91.3M in Q1 2020.
  • 2,214 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2020.

Based on Polar Capital's 13F filing for Q3 2020, filed 16 Nov 2020.